SCHEMBL13720163

SCHEMBL13720163

CN(C[C@]1(c2ccccc2)C[C@H]1C=O)C(=O)OC(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 5/20 0.36
SLC6A2 P23975 2/20 0.36
SLC6A3 Q01959 2/20 0.36
HTR2C P28335 4/20 0.35
OPRM1 P35372 1/20 0.35
OPRL1 P41146 1/20 0.35
RORC P51449 2/20 0.35
PDK2 Q15119 1/20 0.35
BRD4 O60885 1/20 0.34
CREBBP Q92793 1/20 0.34
GBA1 P04062 1/20 0.34
METAP2 P50579 1/20 0.33
HCRTR1 O43613 1/20 0.33
HCRTR2 O43614 1/20 0.33
USP30 Q70CQ3 1/20 0.33
KDM1A O60341 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4681356 1.00 SLC6A4 (0.36) SLC6A4SLC6A2SLC6A3HTR2COPRM1
SCHEMBL13720136 1.00 SLC6A4 (0.36) SLC6A4SLC6A2SLC6A3HTR2COPRM1
SCHEMBL13720388 1.00 SLC6A4 (0.36) SLC6A4SLC6A2SLC6A3HTR2COPRM1
SCHEMBL13720416 1.00 SLC6A4 (0.36) SLC6A4SLC6A2SLC6A3HTR2COPRM1
SCHEMBL13720491 0.89 PDK2 (0.37) SLC6A4SLC6A2SLC6A3HTR2CRORC
SCHEMBL4019257 0.85 SLC6A2 (0.39) SLC6A4SLC6A2SLC6A3HTR2COPRM1
SCHEMBL4028181 0.85 SLC6A2 (0.39) SLC6A4SLC6A2SLC6A3HTR2COPRM1
SCHEMBL4024571 0.85 SLC6A2 (0.39) SLC6A4SLC6A2SLC6A3HTR2COPRM1
SCHEMBL4025554 0.85 SLC6A2 (0.39) SLC6A4SLC6A2SLC6A3HTR2COPRM1
SCHEMBL13720695 0.82 SLC6A2 (0.41) SLC6A4SLC6A2SLC6A3HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7569579-B2 for inhibition of HIV replication and treatment of acquired immune deficiency syndrome SMITHKLINE BEECHAM CORPORATION (US) 2009-08-04 US disclosed
US-7569579-B2 for inhibition of HIV replication and treatment of acquired immune deficiency syndrome SMITHKLINE BEECHAM CORPORATION (US) 2009-08-04 US disclosed
EP-1569934-B1 CYCLOPROPYL COMPOUNDS AS CCR5 ANTAGONISTS SMITHKLINE BEECHAM CORP (US) 2008-01-23 EP disclosed